PDB11 CLINICAL AND COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 ONCE OR TWICE DAILY VERSUS INSULIN GLARGINE IN TYPE 2 DIABETES MELLITUS- A MODELING ANALYSIS IN THE CHINESE SETTING
Abstract
Authors
JL Palmer A Beaudet J White J Plun-Favreau J Smith-Palmer